Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Paolini

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2020
Molecular profiling in Parkinsonian syndromes: CSF biomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Biomolecules|February 26, 2020
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF BiomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Biomarker Insights|October 28, 2020
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF BiomarkersLucia Farotti, Federico Paolini Paoletti, Simone Simoni, et al.
International Journal of Molecular Sciences|June 2, 2021
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple SclerosisFederico Paolini Paoletti, Simone Simoni, Lucilla Parnetti, et al.
BMJ Case Reports|December 21, 2018
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosisFederico Paolini Paoletti, Maria Di Gregorio, Paolo Calabresi, et al.
Journal of Electrocardiology|May 13, 2026
Time is muscle, context is key: Re-evaluating the urgency of aVR ST elevationFederico Paolini, Leonardo Brugiatelli, Alessandro D'Alfonso, et al.
Expert Review of Molecular Diagnostics|September 12, 2024
Research advancement in fluid biomarkers for Parkinson's diseaseLorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics|October 30, 2023
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's diseaseLorenzo Gaetani, Davide Chiasserini, Federico Paolini Paoletti, et al.
NPJ Parkinson'S Disease|November 28, 2018
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohortPaolo Eusebi, Michele Romoli, Federico Paolini Paoletti, et al.
Journal of Translational Medicine|January 28, 2025
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approachAlessia Vignoli, Giovanni Bellomo, Federico Paolini Paoletti, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 7, 2020
Molecular profiling in Parkinsonian syndromes: CSF biomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Biomolecules|February 26, 2020
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF BiomarkersFederico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti
Biomarker Insights|October 28, 2020
Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF BiomarkersLucia Farotti, Federico Paolini Paoletti, Simone Simoni, et al.
International Journal of Molecular Sciences|June 2, 2021
The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple SclerosisFederico Paolini Paoletti, Simone Simoni, Lucilla Parnetti, et al.
BMJ Case Reports|December 21, 2018
Drug-induced Creutzfeldt-Jakob disease-like syndrome: early CSF analysis as useful tool for differential diagnosisFederico Paolini Paoletti, Maria Di Gregorio, Paolo Calabresi, et al.
Journal of Electrocardiology|May 13, 2026
Time is muscle, context is key: Re-evaluating the urgency of aVR ST elevationFederico Paolini, Leonardo Brugiatelli, Alessandro D'Alfonso, et al.
Expert Review of Molecular Diagnostics|September 12, 2024
Research advancement in fluid biomarkers for Parkinson's diseaseLorenzo Gaetani, Federico Paolini Paoletti, Alessandro Mechelli, et al.
Expert Review of Molecular Diagnostics|October 30, 2023
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's diseaseLorenzo Gaetani, Davide Chiasserini, Federico Paolini Paoletti, et al.
NPJ Parkinson'S Disease|November 28, 2018
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohortPaolo Eusebi, Michele Romoli, Federico Paolini Paoletti, et al.
Journal of Translational Medicine|January 28, 2025
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approachAlessia Vignoli, Giovanni Bellomo, Federico Paolini Paoletti, et al.
Pageof 6